Green Thumb Industries

Federal Legalization And Wellness Trends Will Transform Cannabis Markets

AnalystHighTarget

Not Invested

Community Contributor

Published

10 Jul 25

n/a

AnalystHighTarget's Fair Value

n/a

-20.9%

-1.4%

-20.9%

-1.4%

You can edit this narrative until Jul 10 9:31 PM. Then, changes will post as Updates.

Author's Valuation

CA$21.1353.5% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

CA$21.13

53.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.86%

Pharma revenue growth rate

0.68%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.45%

Calculation

US$154.52m

Earnings '28

25.71x

PE Ratio '28

US$3.97b

Market Cap '28

US$3.97b

Market Cap '28

217.60m

No. shares '28

US$18.26

Share Price '28

US$18.26 Share Price '28

Discounted to 2025 @ 6.30% p.a.

US$15.20

Fair Value '25

US$15.20 Fair Value '25

Converted to CAD @ 1.3864 USD/CAD Exchange Rate

CA$21.07

Fair Value '25